SCHRODER INVESTMENT MANAGEMENT GROUP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$1,690,000
+225.6%
153,788
+172.4%
0.00%
+100.0%
Q4 2016$519,000
-29.1%
56,455
-9.1%
0.00%0.0%
Q3 2016$732,000
-22.2%
62,122
-14.5%
0.00%
-50.0%
Q2 2016$941,000
-23.6%
72,697
-6.2%
0.00%
-33.3%
Q1 2016$1,231,00077,4990.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2017
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders